Welcome Guest!  Login | Register | Help
Home News Screener Maps Groups Portfolio Insider Futures Forex Collaborate Store Elite
Abbott Laboratories
IndexS&P 500 P/E30.53 EPS (ttm)1.39 Insider Own0.10% Shs Outstand1.50B Perf Week6.10%
Market Cap63.80B Forward P/E17.25 EPS next Y2.46 Insider Trans7.74% Shs Float1.50B Perf Month0.07%
Income2.16B PEG2.51 EPS next Q0.59 Inst Own68.90% Short Float0.75% Perf Quarter-0.89%
Sales21.82B P/S2.92 EPS this Y319.40% Inst Trans-0.06% Short Ratio2.45 Perf Half Y12.76%
Book/sh15.67 P/B2.71 EPS next Y9.67% ROA5.60% Target Price44.79 Perf Year16.53%
Cash/sh4.70 P/C9.03 EPS next 5Y12.18% ROE10.00% 52W Range35.06 - 43.97 Perf YTD13.18%
Dividend0.88 P/FCF54.25 EPS past 5Y-13.00% ROI8.00% 52W High-3.50% Beta0.63
Dividend %2.07% Quick Ratio1.60 Sales past 5Y-5.80% Gross Margin54.30% 52W Low21.01% ATR0.90
Employees69000 Current Ratio1.90 Sales Q/Q1.90% Oper. Margin12.80% RSI (14)55.77 Volatility2.31% 1.91%
OptionableYes Debt/Eq0.29 EPS Q/Q0.00% Profit Margin11.00% Rel Volume1.00 Prev Close41.59
ShortableYes LT Debt/Eq0.14 EarningsOct 22 BMO Payout46.50% Avg Volume4.57M Price42.43
Recom2.30 SMA202.65% SMA501.04% SMA2006.64% Volume4,582,126 Change2.02%
22-Sep-14Reiterated RBC Capital Mkts Outperform $44 → $48
17-Jul-14Reiterated Stifel Buy $42 → $47
17-Jul-14Reiterated Barclays Equal Weight $40 → $43
10-Mar-14Initiated Singular Research Sell $30
16-Dec-13Reiterated Deutsche Bank Hold $37 → $39
07-Oct-13Reiterated Stifel Buy $44 → $40
18-Jul-13Reiterated Barclays Equal Weight $35 → $37
28-May-13Reiterated RBC Capital Mkts Outperform $38 → $42
21-May-13Initiated Gabelli & Co Buy
19-Apr-13Reiterated RBC Capital Mkts Outperform $37 → $38
18-Apr-13Reiterated Stifel Buy $40 → $44
12-Apr-13Reiterated Deutsche Bank Hold $33 → $35
15-Feb-13Initiated Stifel Nicolaus Buy $40
11-Jan-13Reiterated UBS Buy $75 → $38
11-Jan-13Initiated Barclays Equal Weight $35
04-Jan-13Downgrade Deutsche Bank Buy → Hold $70 → $33
19-Jul-12Reiterated UBS Buy $68 → $72
19-Mar-12Reiterated UBS Buy $62 → $68
19-Mar-12Reiterated RBC Capital Mkts Outperform $60 → $68
09-Dec-11Downgrade Barclays Capital Overweight → Equal Weight $55 → $55
23-Oct-14 11:57AM  Abbott Laboratories (ABT) Earnings Report: Q3 2014 Conference Call Transcript at TheStreet
12:51AM  [$$] Abbott Sales Rise 5.8%; Mylan Terms Revised at The Wall Street Journal
22-Oct-14 06:43PM  Biogen, Thermo Reports Disappoint; Abbott Accelerates at Investor's Business Daily
06:22PM  Abbott, Mylan silent on why changing tax-inversion terms Reuters
04:59PM  Abbott Laboratories Conference Call Highlights Benzinga
12:18PM  Mylan-Abbott Inversion Deal Is On With Some Changes at The Wall Street Journal
10:22AM  Today's Unusual Social Activity Stock: Abbott Laboratories (ABT) at TheStreet
10:15AM  Abbott Labs' (ABT) Earnings Up Y/Y in Q3, Guidance Updated Zacks
09:28AM  [$$] Abbott Laboratories Sales Rise 5.8% at The Wall Street Journal
09:24AM  Abbott, Mylan back generics deal, tweak terms after tax rule change Reuters
09:00AM  Abbott Laboratories Earnings Call scheduled for 9:00 am ET today CCBN
08:50AM  ABBOTT LABORATORIES Files SEC form 8-K, Results of Operations and Financial Condition, Financial Statements and Exhib EDGAR Online
08:11AM  Abbott says third-quarter sales match forecasts Reuters
07:57AM  Abbott tops 3Q profit expectations AP
07:53AM  Abbotts Profit Rises as Nutrition Products Grow at Bloomberg
07:47AM  Abbott Labs shares rise after profit tops forecasts at MarketWatch
07:31AM  Abbott Reports Third-Quarter 2014 Results PR Newswire
07:07AM  Q3 2014 Abbott Laboratories Earnings Release - Before Market Open CCBN
21-Oct-14 08:30PM  [video]What to Watch on Wall Street for Wednesday, October 22nd 2014 at TheStreet
20-Oct-14 03:35PM  Will Abbott Labs (ABT) Miss on Earnings This Quarter? Zacks
11:00AM  New Large-Scale Study Will Look at How Nutrition Can Help Keep Patients from Returning to the Hospital PR Newswire
09:21AM  Jefferies Has 5 Stocks to Buy With Big Catalysts This Week at 24/7 Wall St.
16-Oct-14 04:30PM  Abbott Acknowledged by Science Magazine as a Top Employer PR Newswire
12:23PM  How to Profit From October's Volatile Market at TheStreet
15-Oct-14 05:05AM  Shire Urges AbbVie to Pursue Merger Despite New Inversion Rules at New York Times
14-Oct-14 04:22PM  Stryker Seriously Undervalued At Current Prices at Forbes
10:16AM  Ireland's Double Irish faces its demise at Financial Times
10-Oct-14 01:34PM  3 Big Stocks to Buy in a Volatile Market at TheStreet
10:36AM  Abbott Celebrates the Power of Health and Achievement as First-Ever Title Sponsor of World Marathon Majors PR Newswire
10:36AM  Abbott Celebrates the Power of Health and Achievement as First-Ever Title Sponsor of World Marathon Majors CNW Group
09-Oct-14 03:45PM  Brussels in crackdown on 'double Irish' tax loophole at Financial Times
07:08AM  Hillary Clinton Open to GOP Obamacare Demand on Medical Devices at Bloomberg
06-Oct-14 03:00PM  How Insurers Curb Costly Hips, Knees And Other Medical Devices at Forbes
01:03PM  Today's Top Performers In Health Services at TheStreet
02-Oct-14 12:01AM  You Talking About Your Weight on Facebook? Hedge Funds Are Listening Bloomberg
01-Oct-14 10:00AM  Abbott Goes Extra Mile in Commitment to Helping People Live Healthy Lives as an Official Sponsor of 2014 Bank of America Chicago Marathon PR Newswire
08:50AM  Abbott Labs Completes CFR Pharmaceuticals Acquisition Zacks
08:30AM  Abbott Hosts Conference Call for Third-Quarter Earnings PR Newswire
26-Sep-14 09:28AM  ABBOTT LABORATORIES Files SEC form 8-K, Completion of Acquisition or Disposition of Assets, Financial Statements and EDGAR Online
09:00AM  Abbott Completes Acquisition of CFR Pharmaceuticals; Announces Results of Tender Offer for CFR Shares PR Newswire
25-Sep-14 07:56PM  Abbott, AbbVie win dismissal of claims over Humira, AndroGel Reuters
07:35AM  The Zacks Analyst Blog Highlights: Medtronic, Covidien, Abbott Laboratories, Mylan and Burger King WorldwideThe Zacks Analyst Blog Highlights: Medtronic, Covidien, Abbott Laboratories, Mylan and Burger King Worldwide Zacks
24-Sep-14 11:03PM  Ex-CEO charged in ballplayer's insider trade AP
08:22PM  Ex-Advanced Medical Optics CEO Indicted in Insider Case at Bloomberg
09:22AM  Will New Treasury Rules Contain Tax Inversions? Zacks
09:00AM  Expiration of the U.S. Tender Offer for CFR Pharmaceuticals S.A. PR Newswire
06:10AM  Never Mind What Lew or Bill Clinton or Camp Say: Opening Line at Bloomberg
23-Sep-14 02:45PM  Tax crackdown impact on pharma deals CNBC
02:45PM  [video] Tax crackdown impact on pharma deals at CNBC
10:24AM  [video] Treasury Secretary Jacob Lew Unveils Steps to Curb Tax Inversions at TheStreet
08:21AM  U.S. move on tax-dodging mergers hits drugs stocks at CNNMoney.com
07:02AM  Tax inversion move: The deals which might suffer at CNBC
01:55AM  India's withdrawal of drug price cap guidelines to be on prospective basis Reuters
01:30AM  India withdraws regulator's power to cap non-essential drug prices Reuters
22-Sep-14 05:20PM  Novo Nordisk Reveals Fresh Data on Xultophy for Diabetes Zacks
09:30AM  China very important for world growth: Cramer CNBC
09:30AM  [video] China very important for world growth: Cramer at CNBC
19-Sep-14 05:26PM  Today's Market Thorns, Roses, and All Time Highs... Yahoo Finance Blogs
18-Sep-14 10:31AM  The best companies for working mothers Yahoo Finance
16-Sep-14 09:11AM  Abbott Included In Top 10 Best Companies by Working Mother Magazine PR Newswire
08:00AM  The Keys In This Market: Income & Growth at Forbes
15-Sep-14 07:20PM  New York Files Antitrust Suit Against Alzheimers Drug Maker at New York Times
04:20PM  Abbott Labs Presents Positive One-Year Data on Absorb Zacks
09:30AM  Abbott Initiates ABSORB IV Trial to Evaluate Quality of Life and Cost Savings of Dissolving Heart Device PR Newswire
07:52AM  Attunity, Ltd. (ATTU) in Focus: Stock Adds 5.2% in Session Zacks
14-Sep-14 11:00AM  ABSORB II Study Shows Abbott's Dissolving Heart Device Comparable to the World's Leading Heart Stent PR Newswire
11:00AM  Abbotts Dissolving Heart Stent Clears Arteries in Trial at Bloomberg
11:00AM  Abbott dissolving stent has lower angina rate vs metal stent -study Reuters
12-Sep-14 04:05PM  AbbVie's Humira Positive in Phase III Skin Disease Study Zacks
03:50PM  Abbott Labs (ABT) to Repurchase Shares for $3B Zacks
11-Sep-14 04:20PM  Mylan to Acquire U.S. Rights to Arixtra for up to $300M Zacks
02:48PM  [$$] Abbott Labs Sets $3 Billion Buyback at The Wall Street Journal
02:29PM  Abbott Laboratories (ABT) Declares Quarterly Dividend, Announces Share Buyback at TheStreet
01:39PM  Abbott Announces New $3 Billion Share Repurchase Program, Declares Dividend PR Newswire
10:44AM  Abbott Once Again Named the Industry Leader for Responsible and Sustainable Business on the Dow Jones Sustainability Index (DJSI) PR Newswire
10-Sep-14 10:06AM  [video] Sen. Schumer's inversion compromise at CNBC
08-Sep-14 03:35PM  [video] Pursuing tax inversion solutions at CNBC
02:53PM  FTC sues AbbVie, Teva over generic AndroGel AP
09:24AM  New Abbott Technology May Uncover the Root of Critical Infections and Cut Health Care Costs PR Newswire
05-Sep-14 03:35PM  Abbott Labs' FreeStyle Libre Flash Glucose Gets CE Mark Zacks
06:00AM  Abbott Labs' Weakness in Devices Hurts Long-Term Growth Potential at TheStreet
04-Sep-14 03:38PM  Google's Calico in $500M Joint Venture with AbbVie Zacks
02:38PM  [video] Diabetes monitoring goes mobile at CNBC
03-Sep-14 03:18PM  FDA: Little evidence to support testosterone drugs AP
01:03PM  3 Health Services Stocks Moving The Industry Upward at TheStreet
09:30AM  Abbott Receives CE Mark for FreeStyle┬« Libre, a Revolutionary Glucose Monitoring System for People with Diabetes PR Newswire
28-Aug-14 02:13PM  Abbott: A Brighter Future Gurufocus
10:38AM  [video] Santelli Exchange: Truth about inversions at CNBC
26-Aug-14 12:00AM  Boehner Joins Camp in Profiting From Corporate Effort to Escape U.S. Taxes Bloomberg
25-Aug-14 09:10AM  ABBOTT LABORATORIES Files SEC form 8-K, Other Events, Financial Statements and Exhibits EDGAR Online
09:00AM  Abbott Commences Tender Offer for All Outstanding Ordinary Shares and American Depositary Shares of CFR Pharmaceuticals S.A. PR Newswire
23-Aug-14 07:00AM  A Shift in Health-Care M&A Activity Morningstar
22-Aug-14 04:55PM  Johnson & Johnson vs. Abbott Laboratories in the Battle for Emerging Market Turf at TheStreet
19-Aug-14 06:27PM  This stock may be hazardous to your financial health Talking Numbers
10:45AM  You've got obesity all wrong: Zafgen CEO at CNBC
18-Aug-14 09:00AM  Abbott Joins Forces with U.S. Department of Defense to Develop Portable Blood Tests for Evaluating Concussions PR Newswire
15-Aug-14 07:02PM  Abbott, AbbVie Win Dismissal of Suit Over Depakote Marketing at Bloomberg
10:32AM  Do We Really Trust Corporations To Investigate Their Own Profitable Impropriety? at Forbes
12-Aug-14 01:04PM  ABBOTT LABORATORIES Financials EDGAR Online Financials
10:06AM  5 Companies That Have Moved Overseas For Lower Taxes Benzinga
Abbott Laboratories manufactures and sells health care products worldwide. Its Established Pharmaceutical Products segment offers branded generic pharmaceuticals for the treatment of pancreatic exocrine insufficiency, irritable bowel syndrome, intrahepatic cholestasis or depressive symptoms, gynecological disorders, dyslipidemia, hypertension, hypothyroidism, pain, fever, and inflammation; and regulates physiological rhythm of the colon, as well as provides hormone replacement therapy and anti-infective and influenza vaccines. The company's Diagnostic Products segment provides diagnostic systems and tests, such as immunoassay and clinical chemistry systems; assays for screening and diagnosis for drugs of abuse, cancer, therapeutic drug monitoring, fertility, and physiological and infectious diseases; hematology systems and reagents; genomic-based tests; informatics and automation solutions; and diagnostic systems and tests for blood analysis, as well as instruments that automate the extraction, purification, and preparation of DNA and RNA from patient samples, and detects and measures infectious agents. Its Nutritional Products segment offers pediatric and adult nutritional products, such as various forms of prepared infant and follow-on formula. The company's Vascular Products segment provides coronary, endovascular, vessel closure, and structural heart devices for the treatment of vascular diseases. Abbott Laboratories also offers blood glucose and glucose monitoring systems, test strips, and data management software and accessories for people with diabetes; and medical devices for the eye, such as cataract surgery, LASIK surgery, and contact lens care and dry eye products. The company primarily serves retailers, wholesalers, hospitals, health care facilities, laboratories, physicians' offices, and government agencies. It has strategic alliance with Fonterra Co-operative Group Ltd. The company was founded in 1888 and is headquartered in Abbott Park, Illinois.
Insider Trading Relationship Date Transaction Cost #Shares Value ($) #Shares Total SEC Form 4
Fussell Stephen RExecutive Vice PresidentSep 18Option Exercise22.7931,900726,872141,664Sep 19 05:10 PM
FREYMAN THOMAS CExecutive Vice PresidentJul 21Option Exercise24.0779,0001,901,828390,326Jul 22 05:03 PM
Landgraf John CExecutive Vice PresidentJun 03Option Exercise31.9118,203580,771113,334Jun 05 05:09 PM
Blaser Brian JExecutive Vice PresidentMar 03Sale39.011,44156,219102,895Mar 04 05:07 PM
Mason Heather LSenior Vice PresidentMar 03Sale38.952,19685,540118,410Mar 04 05:07 PM
Funck Robert EVice President, ControllerMar 03Sale38.971,41355,06862,926Mar 04 05:05 PM
ALLEN HUBERT LExecutive Vice PresidentMar 03Sale39.031,54360,22952,525Mar 04 05:06 PM
Foltz Charles DSenior Vice PresidentMar 03Sale38.951,58861,85465,318Mar 04 05:06 PM
ASHLEY RICHARD WExecutive Vice PresidentMar 03Sale39.002,09881,829333,072Mar 04 05:06 PM
Warmuth Michael JExecutive Vice PresidentMar 03Sale39.0116,484642,96615,851Mar 04 05:04 PM
Contreras JaimeSenior Vice PresidentMar 03Sale39.378,081318,16030,136Mar 04 05:05 PM
FREYMAN THOMAS CExecutive Vice PresidentMar 03Sale39.102,984116,686311,326Mar 04 05:05 PM
Landgraf John CExecutive Vice PresidentMar 03Sale39.3817,293681,05795,131Mar 04 05:04 PM
Doyle Katherine C.Senior Vice PresidentMar 03Sale39.016,639258,96447,525Mar 04 05:04 PM
Landgraf John CExecutive Vice PresidentFeb 18Option Exercise35.031,58355,452104,004Feb 19 06:54 PM
Contreras JaimeSenior Vice PresidentFeb 18Sale38.9662124,1911,067Feb 19 06:53 PM
Pavee Jean-YvesSenior Vice PresidentFeb 18Sale38.9748919,05429,479Feb 19 05:06 PM
ALLEN HUBERT LExecutive Vice PresidentFeb 18Sale39.0733313,00941,033Feb 19 05:06 PM
Landgraf John CExecutive Vice PresidentFeb 18Sale39.101,58361,899102,421Feb 19 06:54 PM
Landgraf John CExecutive Vice PresidentFeb 07Option Exercise32.1621,972706,529124,393Feb 11 05:05 PM
Landgraf John CExecutive Vice PresidentFeb 07Sale36.9621,972811,981102,421Feb 11 05:05 PM
Funck Robert EVice President, ControllerJan 31Option Exercise33.569,398315,40469,626Feb 04 05:02 PM
Funck Robert EVice President, ControllerJan 31Sale36.209,398340,19460,228Feb 04 05:02 PM
Warmuth Michael JExecutive Vice PresidentJan 29Option Exercise31.9111,430364,68451,917Jan 31 05:01 PM
Warmuth Michael JExecutive Vice PresidentJan 29Sale36.2111,430413,83240,487Jan 31 05:01 PM
Pavee Jean-YvesSenior Vice PresidentDec 06Option Exercise25.075,855146,80436,756Dec 10 05:05 PM
Pavee Jean-YvesSenior Vice PresidentDec 06Sale37.465,855219,29930,901Dec 10 05:05 PM
Foltz Charles DSenior Vice PresidentDec 05Option Exercise24.732,03050,19255,978Dec 09 05:25 PM
Foltz Charles DSenior Vice PresidentDec 05Sale37.031,71663,53554,262Dec 09 05:25 PM
WHITE MILES DChairman and CEONov 22Option Exercise33.37300,40110,024,3811,689,653Nov 26 05:14 PM
WHITE MILES DChairman and CEONov 22Sale38.12150,5275,738,4371,539,126Nov 26 05:14 PM
WHITE MILES DChairman and CEONov 22Sale38.26149,8745,734,0961,389,252Nov 26 05:14 PM
Fussell Stephen RExecutive Vice PresidentNov 08Option Exercise19.721,22724,192101,811Nov 08 05:08 PM
Fussell Stephen RExecutive Vice PresidentNov 07Option Exercise25.2710,466264,492111,050Nov 08 05:08 PM
Fussell Stephen RExecutive Vice PresidentNov 07Sale37.5910,466393,417100,584Nov 08 05:08 PM
Contreras JaimeSenior Vice PresidentOct 30Option Exercise35.082,71595,2424,781Nov 01 05:04 PM
Contreras JaimeSenior Vice PresidentOct 30Option Exercise33.4922,653758,57346,386Nov 01 05:04 PM
Contreras JaimeSenior Vice PresidentOct 30Sale37.012,715100,4852,066Nov 01 05:04 PM
Contreras JaimeSenior Vice PresidentOct 30Sale36.8322,653834,23123,733Nov 01 05:04 PM